Arcus Biosciences COO Jennifer Jarrett's 2021 pay jumps 42% to $16M
Arcus Biosciences reports 2021 executive compensation
By ExecPay News
Published: April 20, 2022
Arcus Biosciences reported fiscal year 2021 executive compensation information on April 20, 2022.
In 2021, six executives at Arcus Biosciences received on average a compensation package of $6.5M, a 21% increase compared to previous year.
Average pay of disclosed executives at Arcus Biosciences
Jennifer Jarrett, Chief Operating Officer, received $16M in total, which increased by 42% compared to 2020. 95% of Jarrett's compensation, or $15M, was in stock awards. Jarrett also received $300K in non-equity incentive plan, $525K in salary, as well as $3.2K in other compensation.
For fiscal year 2021, the median employee pay was $296,616 at Arcus Biosciences. Therefore, the ratio of Jennifer Jarrett's pay to the median employee pay was 52 to one.
Terry Rosen, Chief Executive Officer, received a compensation package of $9.5M, which increased by 67% compared to previous year. 73% of the compensation package, or $6.9M, was in option awards.
Juan Carlos Jaen, President and Director, earned $4.4M in 2021, a 17% increase compared to previous year.
William Grossman, Chief Medical Officer, received $3.9M in 2021, which decreases by 36% compared to 2020.
Robert C. Goeltz, II, Chief Financial Officer, earned $2.9M in 2021, a 22% decrease compared to previous year.
Carolyn Tang, General Counsel, received $2.9M in 2021, which increases by 30% compared to 2020.
Related executives
Terry Rosen
Arcus Biosciences
Chief Executive Officer
Robert Goeltz
Arcus Biosciences
Chief Financial Officer
Juan Jaen
Arcus Biosciences
President and Director
Jennifer Jarrett
Arcus Biosciences
Chief Operating Officer
Carolyn Tang
Arcus Biosciences
General Counsel
William Grossman
Arcus Biosciences
Chief Medical Officer
You may also like
Source: SEC filing on April 20, 2022.